Jeff Jensen

Biography

  Jeff has more than 20 years experience in the bioscience and industrial sectors. He has started and led companies that have developed numerous novel products in chemical and biological analysis, drug delivery, and diagnostics. Prior to Fluxion, Jeff served as President and CEO of Eksigent Technologies (acquired by Danaher), a leading supplier of microfluidic platforms for bio-analytical and medical device applications. Prior to Eksigent, Jeff held management positions in numerous functions at Raychem and Pall Corporation. Jeff received his BS from Cornell University in Chemical Engineering and graduated from the Program for Management Development at Harvard Business School.  

Research Interest

 Biotechnology